Search details
1.
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.
Diabetes Metab Res Rev
; 37(7): e3430, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33369842
2.
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.
Diabetes Obes Metab
; 23(7): 1588-1593, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33687748
3.
Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study.
Diabetes Obes Metab
; 23(8): 1892-1901, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33914401
4.
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial.
Diabetes Obes Metab
; 22(9): 1664-1669, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32314521
5.
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.
Diabetes Obes Metab
; 22(8): 1369-1377, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32243043
6.
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study.
Diabetes Obes Metab
; 22(3): 346-354, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31646724
7.
Nearly a Century of Insulin at Sanofi: Looking Back Over the Decades of Production and Development.
Pediatr Endocrinol Rev
; 17(Suppl 1): 161-169, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-32208560
8.
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study.
Diabetes Obes Metab
; 21(9): 2123-2132, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31144445
9.
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.
Diabetes Obes Metab
; 20(9): 2148-2158, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29938887
10.
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Diabetes Ther
; 11(4): 1017-1027, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32100192
11.
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Diabetes Ther
; 11(7): 1607-1608, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32361833
12.
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Diabetes Ther
; 11(8): 1907-1908, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32578133
13.
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.
Curr Med Res Opin
; 36(4): 571-581, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31865758
14.
Predictive Modeling of Hypoglycemia Risk with Basal Insulin Use in Type 2 Diabetes: Use of Machine Learning in the LIGHTNING Study.
Diabetes Ther
; 10(2): 605-615, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30767172
15.
Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study.
Diabetes Ther
; 10(2): 617-633, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30767173
16.
Postpartum adiponectin concentration, insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances.
Prev Cardiol
; 11(2): 106-15, 2008.
Article
in English
| MEDLINE | ID: mdl-18401239
17.
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Diabetes Care
; 41(10): 2147-2154, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30104294
18.
Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled Analysis.
Low Urin Tract Symptoms
; 9(2): 82-88, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28394498
19.
Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
Eur Urol
; 68(3): 386-96, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25484142
20.
Heterogeneous effect of gestational weight gain on birth weight: quantile regression analysis from a population-based screening.
Ann Epidemiol
; 25(2): 133-7, 137.e1, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25497913